Publications
47
Citations
283
Est. group size
~26
Recurring co-author estimate
Active years
13
Publishing since 2014
Logan Roof's work focuses on thoracic and head-and-neck cancers, including non-small cell and small cell lung cancer, mesothelioma, and squamous cell carcinomas of the head and neck. Much of the research examines treatment approaches such as immunotherapy, targeted drug therapy, and radiation, as well as clinical guidelines and disparities in outcomes based on demographic and socioeconomic factors. This research is largely clinical in nature, drawing on national cancer databases and clinical trial data.
Publication output has grown substantially over the last decade, rising from about 1-2 papers per year in 2017-2021 to 9-11 papers per year in 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- WBC Growth Factors: ASCO Guideline Update
Journal of Clinical Oncology · 2026
- Clinical Importance of Molecular Biomarkers in Pleural Mesothelioma
Cancers · 2026
- Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2
Journal of Clinical Oncology · 2026
- PP01.26: Real-World Time Toxicity of Tarlatamab in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Journal of Thoracic Oncology · 2026
- Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1
Journal of Clinical Oncology · 2025
- Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report
Journal of Thoracic Oncology · 2025
- Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1
Journal of Clinical Oncology · 2024
- Demographic Disparities in Lung Cancer Mortality and Trends in the United States From 1999 Through 2020: A Population-Based CDC Database Analysis
Journal of the National Comprehensive Cancer Network · 2024
- Mesothelioma and Immunotherapies
touchREVIEWS in Oncology & Haematology · 2024
- Immunotherapy in HPV-Related Oropharyngeal Cancers
Current Treatment Options in Oncology · 2023
- Clinical Utility of Cabozantinib in the Treatment of Locally Advanced or Metastatic Differentiated Thyroid Carcinoma: Patient Selection and Reported Outcomes
Cancer Management and Research · 2023
- Patterns and outcomes of palliative radiation therapy with immunotherapy in locally recurrent head and neck squamous cell carcinoma.
Journal of Clinical Oncology · 2023
- Demographic disparities in lung cancer mortality and trends in the United States between 1999 and 2020: A population-based CDC database analysis.
Journal of Clinical Oncology · 2023
- P2.18-03 Impact of Inclusion of Immunotherapy in National Treatment Guidelines on Survival Outcomes in Malignant Pleural Mesothelioma
Journal of Thoracic Oncology · 2023
- Impact of Socioeconomic Factors on Overall Survival in SCLC
JTO Clinical and Research Reports · 2022
- Journal of Clinical Oncology×13
- Journal of the National Comprehensive Cancer Network×6
- Journal of Thoracic Oncology×5
- JTO Clinical and Research Reports×2
- Regular and Young Investigator Award Abstracts×2
- D. Carbone
Medicine · The Ohio State University
- Misty Dawn Shields
Medicine · Indiana University
- Jing Su
Medicine · Indiana University
- Gregory A. Otterson
Medicine · The Ohio State University
- Tamio Okimoto
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile